![Satoshi Yamamoto](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Satoshi Yamamoto
Corporate Officer/Principal bei Banyu Pharmaceutical Co. Ltd.
Ursprung des Netzwerks ersten Grades von Satoshi Yamamoto
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Banyu Pharmaceutical Co. Ltd.
![]() Banyu Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Banyu Pharmaceutical Co. Ltd. produces and distributes pharmaceutical products. It researches, develops, manufactures, sells, and imports and exports ethical drugs in Japan. Banyu Pharmaceutical was founded in 1915 and is headquartered in Tokyo, Japan.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Satoshi Yamamoto
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
MERCK & CO., INC. | Pharmaceuticals: Major | President | |
The University of Sydney | College/University | Undergraduate Degree | |
CSL LIMITED | Biotechnology | Director/Board Member | |
ALKERMES PLC | Pharmaceuticals: Major | Director/Board Member | |
The University of Sydney USA Foundation | Director/Board Member | ||
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
Alkermes, Inc.
![]() Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
Us Foundation of The University of The Valley of Guatemala | Director/Board Member | ||
NeuClone Pty Ltd.
![]() NeuClone Pty Ltd. BiotechnologyHealth Technology NeuClone Pty Ltd. develops biological products. It provides NeuMAX, a platform technology for manufacturing protein therapeutics. The firm offers cell lines engineering services for manufacturing biological drugs. The company was founded by Noelle Sunstrom in 2007 and is headquartered in Sydney, Australia. | Biotechnology | Director/Board Member | |
National Pharmaceutical Council
![]() National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Chairman | |
United States Studies Centre | College/University | Director/Board Member | |
Neuclone Pharmaceuticals Pty Ltd.
![]() Neuclone Pharmaceuticals Pty Ltd. BiotechnologyHealth Technology Neuclone Pharmaceuticals Pty Ltd. manufactures biological products. The private company is based in Sydney, Australia. | Biotechnology | Director/Board Member | |
Nagoya University | College/University | Graduate Degree | |
University of Shizuoka | College/University | Doctorate Degree | |
REGiMMUNE Corp.
![]() REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
Vereinigte Staaten | 7 |
Japan | 5 |
Australien | 5 |
Irland | 2 |
Sektoral
Health Technology | 8 |
Consumer Services | 5 |
Commercial Services | 3 |
Operativ
Director/Board Member | 12 |
Corporate Officer/Principal | 3 |
President | 3 |
Independent Dir/Board Member | 3 |
Chairman | 3 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
David Anstice | 13 |
Kunio Suzuki | 4 |
Yasunori Goto | 1 |
Kenjiro Nagasaka | 1 |
- Börse
- Insiders
- Satoshi Yamamoto
- Unternehmensverbindungen